2.14.1 Target Risk Levels
Carcinogenic Health Effects. The total cumulative cancer risk estimate for an AOI
shall not exceed the target risk level (1E-06 to 1E-04) approved by the Department for
the Option being implemented. The total cumulative cancer risk shall include all COC
and exposure pathways identified for each receptor population and shall be estimated as
follows: Total Risk = [(AOIC
1
/RS
1
) + (AOIC
2
/RS
2
) +…+ (AOIC
i
/RS
i
)] x 10
-6
. If the
total cumulative cancer risk estimate exceeds the target risk, then typically, corrective
action shall be warranted. Carcinogenic COC, exposure pathways, and media screened
out under previously completed Options shall not be included in the calculation of the
total cumulative cancer risk for the Option currently being implemented at the AOI.
Screening Standards and RECAP Standards shall be based on a target cancer risk of 10
-6
in accordance with EPA guidelines and policy (Risk Assessment Guidance for Superfund
Volume I Human Health Evaluation Manual Part B Development of Risk-Based
Preliminary Remediation Goals, EPA 1991; Soil Screening Guidance, EPA 1996;
Supplemental Guidance for Developing Soil Screening Levels for Superfund Sites, EPA
2001; Role of Baseline Risk Assessment in Superfund Remedy Selection Decisions, EPA
1991; NCP 40 CFR 300.430(e)(2); Risk-based Concentration Tables, EPA Region III;
EPA Region IV; Human Health Medium-Specific Screening Levels, EPA Region VI; and
Preliminary Remediation Goals EPA Region IX. For carcinogens, it is generally
assumed that setting a 10
-6
target risk level for individual constituents and pathways will
result in a total cumulative cancer risk that is within the acceptable risk range of 10
-6
to
10
-4
(Soil Screening Guidance, EPA 1996). Under MO-3, an alternate target risk level
may be approved by the Department for the development of site-specific MO-3 RS if
warranted by site-specific conditions. An alternate target cancer risk level will only be
considered acceptable for the development of site-specific MO-3 RS when it can be
demonstrated that the total cumulative cancer risk for a RME scenario is less than or
within the target range of 10
-6
to 10
-4
. The use of a target cancer risk level above 10
-6
shall be justified based on site-specific conditions, the level of certainty in the nature and
extent of impact (level of certainty in the site characterization and analytical data), the
level of certainty in the nature and extent of exposure, the level of confidence in the risk
assessment results, and technical factors. Other considerations include compliance with
ARAR, cumulative effect of multiple COC, the potential for human exposure from other
pathways at the AOC or the AOI, population sensitivities, potential impacts on
environmental receptors, cross-media impacts, financial assurance/commitment, future
site use, the reliability of alternatives, the weight-of-scientific evidence concerning
exposures, quantitation limits for the COC, technical limitations to remediation, the
ability to monitor and control movement of COC, and background levels of COC. The
Department has a preference for site management decisions that meet the more protective
end of the target range (i.e., 10
-6
). For an AOI where a total cumulative risk level above
10
-6
is deemed acceptable by the Department, the risks associated with all carcinogens
detected on-site shall be considered in the estimation of: (a) cumulative cancer risks; and
(b) cumulative risks associated with residual constituent concentrations following
corrective action to document that the total cumulative cancer risk is at or below 10
-4
. It
should be noted that corrective action may be warranted even if the cancer risk is within
LDEQ RECAP 2003 65